Jay J. Levy

1.8k total citations
25 papers, 1.2k citations indexed

About

Jay J. Levy is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jay J. Levy has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Oncology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jay J. Levy's work include Bone health and treatments (10 papers), Chemical Synthesis and Analysis (7 papers) and Fibroblast Growth Factor Research (5 papers). Jay J. Levy is often cited by papers focused on Bone health and treatments (10 papers), Chemical Synthesis and Analysis (7 papers) and Fibroblast Growth Factor Research (5 papers). Jay J. Levy collaborates with scholars based in United States, Israel and Switzerland. Jay J. Levy's co-authors include Michael Rosenblatt, Roberta L. McKee, Mark E. Goldman, Michael Chorev, Michael P. Caulfield, Ruth F. Nutt, Richard D. DiMarchi, Jane E. Reagan, John Fisher and Thomas L. Clemens and has published in prestigious journals such as Science, Biochemistry and Biophysical Journal.

In The Last Decade

Jay J. Levy

25 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jay J. Levy United States 15 799 487 151 137 126 25 1.2k
Agnieszka Strzelecka‐Kiliszek Poland 20 539 0.7× 71 0.1× 16 0.1× 180 1.3× 71 0.6× 45 1.0k
Huidong Yuan China 14 1.4k 1.7× 168 0.3× 25 0.2× 37 0.3× 17 0.1× 17 1.7k
Kohji Kasahara Japan 22 1.1k 1.3× 107 0.2× 72 0.5× 23 0.2× 22 0.2× 60 1.6k
Masashi Shin Japan 15 556 0.7× 118 0.2× 97 0.6× 26 0.2× 6 0.0× 58 920
Satoko Kobayashi Japan 15 414 0.5× 69 0.1× 128 0.8× 34 0.2× 11 0.1× 31 925
Jolanta Fertala United States 17 625 0.8× 208 0.4× 55 0.4× 8 0.1× 71 0.6× 36 924
Kristmundur Sigmundsson Sweden 17 512 0.6× 330 0.7× 23 0.2× 41 0.3× 5 0.0× 26 1.0k
Ana M. Bajo Spain 22 483 0.6× 385 0.8× 94 0.6× 212 1.5× 11 0.1× 64 1.2k
Matteo Villain United States 16 772 1.0× 171 0.4× 251 1.7× 12 0.1× 6 0.0× 28 1.2k
Christopher W. Borysenko United States 14 395 0.5× 134 0.3× 48 0.3× 26 0.2× 64 0.5× 18 633

Countries citing papers authored by Jay J. Levy

Since Specialization
Citations

This map shows the geographic impact of Jay J. Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay J. Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay J. Levy more than expected).

Fields of papers citing papers by Jay J. Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay J. Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay J. Levy. The network helps show where Jay J. Levy may publish in the future.

Co-authorship network of co-authors of Jay J. Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Jay J. Levy. A scholar is included among the top collaborators of Jay J. Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay J. Levy. Jay J. Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Fa, Alexander N. Zaykov, Jay J. Levy, Richard D. DiMarchi, & John P. Mayer. (2016). Chemical synthesis of peptides within the insulin superfamily. Journal of Peptide Science. 22(5). 260–270. 43 indexed citations
2.
Chabenne, Joseph R., Yan Zhao, Jay J. Levy, et al.. (2014). A glucagon analog chemically stabilized for immediate treatment of life-threatening hypoglycemia. Molecular Metabolism. 3(3). 293–300. 46 indexed citations
3.
Cantel, Sonia, José A. Halperin, Michael Chorev, et al.. (2009). Side chain-to-Side chain Cyclization by Intramolecular Click Reaction - Building Blocks, Solid Phase Synthesis and Conformational Characterization. Advances in experimental medicine and biology. 611. 175–176. 4 indexed citations
4.
5.
Földes, J., Mei‐Shu Shih, & Jay J. Levy. (1992). Bone structure and calcium metabolism in obese Zucker rats.. PubMed. 16(2). 95–102. 45 indexed citations
6.
McKee, Roberta L., John Fisher, Jay J. Levy, et al.. (1991). Solid-phase synthesis and biologic activity of human parathyroid hormone(1–84). Journal of Bone and Mineral Research. 6(8). 781–789. 6 indexed citations
7.
Caulfield, Michael P., Roberta L. McKee, Mark E. Goldman, et al.. (1990). Parathyroid hormone-related protein (PTHrP): Studies with synthetic peptides indicate that parathyroid hormone and PTHrP interact with the same receptor. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 17(7). 633–637. 3 indexed citations
9.
Chorev, Michael, Mark E. Goldman, Roberta L. McKee, et al.. (1990). Modifications of position 12 in a parathyroid hormone and parathyroid hormone-related protein: toward the design of highly potent antagonists. Biochemistry. 29(6). 1580–1586. 54 indexed citations
10.
Tosteson, Magdalena T., Osvaldo Álvarez, Wayne L. Hubbell, et al.. (1990). Primary structure of peptides and ion channels. Role of amino acid side chains in voltage gating of melittin channels. Biophysical Journal. 58(6). 1367–1375. 42 indexed citations
12.
Rosenberg, Jacob, Mark Pines, Jay J. Levy, et al.. (1989). Renal and Adrenal Adenosine 3′,5′-Monophosphate Production and Corticosteroid Secretion in Response to Synthetic Chicken Parathyroid Hormone-(1–34)*. Endocrinology. 125(2). 1082–1089. 7 indexed citations
13.
Goldman, Mark E., Michael Chorev, Jane E. Reagan, et al.. (1988). Evaluation of Novel Parathyroid Hormone Analogs Using a Bovine Renal Membrane Receptor Binding Assay. Endocrinology. 123(3). 1468–1475. 57 indexed citations
14.
Caulfield, Michael P., Jay J. Levy, Roberta L. McKee, et al.. (1988). AVIAN (CHICKEN) PARATHYROID HORMONE: SYNTHESIS AND COMPARATIVE BIOLOGICAL EVALUATION OF THE 1-34 FRAGMENT. Endocrinology. 123(6). 2949–2951. 11 indexed citations
15.
Rosenblatt, Michael, Michael P. Caulfield, John Fisher, et al.. (1988). A Tumor‐Secreted Protein Associated with Human Hypercalcemia of Malignancy. Annals of the New York Academy of Sciences. 548(1). 137–145. 3 indexed citations
16.
McKee, Roberta L., Mark E. Goldman, Michael P. Caulfield, et al.. (1988). THE 7–34-FRAGMENT OF HUMAN HYPERCALCEMIA FACTOR IS A PARTIAL AGONIST/ANTAGONIST FOR PARATHYROID HORMONESTIMULATED CAMP PRODUCTION. Endocrinology. 122(6). 3008–3010. 56 indexed citations
17.
Tosteson, Magdalena T., Michael P. Caulfield, Jay J. Levy, Michael Rosenblatt, & D. C. Tosteson. (1988). The synthetic precursor specific region of pre-pro-parathyroid hormone forms ion channels in lipid bilayers. Bioscience Reports. 8(2). 173–183. 11 indexed citations
18.
Goldman, Mark E., Roberta L. McKee, Michael P. Caulfield, et al.. (1988). A NEW HIGHLY POTENT PARATHYROID HORMONE ANTAGONIST: [D-TRPl2,TYR34]bPTH-(7–34)NH2. Endocrinology. 123(5). 2597–2599. 49 indexed citations
19.
Tosteson, Magdalena T., Jay J. Levy, Lynn Helena Caporale, Michael Rosenblatt, & D. C. Tosteson. (1987). Solid-phase synthesis of melittin: purification and functional characterization. Biochemistry. 26(21). 6627–6631. 50 indexed citations
20.
Horiuchi, Noboru, Michael P. Caulfield, John Fisher, et al.. (1987). Similarity of Synthetic Peptide from Human Tumor to Parathyroid Hormone in Vivo and in Vitro. Science. 238(4833). 1566–1568. 290 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026